Skip to main content
. 2023 Dec 5;12:139. doi: 10.1186/s13756-023-01345-6

Table 2.

Clinical characteristics of study participants

Characteristics Categories HCAIs (n = 30) Non-HCAIs (n = 320) Overall (N = 350)
n(%) n(%) n(%)
Referral case Yes 0 (0.0) 56 (17.5) 56 (16.0)
No 30 (100) 264 (82.5) 294 (84.0)
Referring healthcare facility Sekou Toure RRH NA 20 (35.7) 20 (35.7)
Geita RRH NA 17 (30.3) 17 (30.3)
Musoma RRH NA 10 (17.9) 10 (17.9)
Kitete NA 7 (12.5) 7 (12.5)
Kamanga Hospital NA 1 (1.8) 1 (1.8)
Bunda NA 1 (1.8) 1 (1.8)
Mobility at admission Bedridden 10 (33.3) 49 (15.3) 59 (16.9)
Wheelchair 15 (50.0) 119 (37.2) 134 (38.3)
Ambulant 5 (16.7) 152 (47.5) 157 (44.9)
Chief complain during current hospital admission Hemiplegia 4 (13.3) 47 (14.7) 51 (14.6)
Hematemesis 2 (6.7) 30 (9.3) 32 (9.1)
Epigastric pain 2 (6.7) 23 (7.2) 25 (7.1)
GBW 3 (10.0) 40 (12.5) 43 (12.3)
DIB + anasarca 2 (6.7) 18 (5.6) 20 (5.7)
Confusion 4 (13.3) 15 (4.7) 19 (5.4)
Anuria 2 (6.7) 14 (4.4) 16 (4.5)
Chest pain 1 (3.3) 13 (4.1) 14 (4.0)
Joint pain 1 (3.3) 13 (4.1) 14 (4.0)
Aphasia 3 (10.0) 9 (2.8) 12 (3.4)
Palpations 0 (0.0) 10 (3.1) 10 (2.9)
Others* 6 (20.0) 88 (27.5) 94 (26.9)
Presence of invasive device No 0 (0.0) 2 (0.6) 2 (0.6)
Yes 30 (100) 318 (99.4) 348 (99.4)
Type of invasive device IV line 24 (80.0) 301 (94.6) 325 (93.4)
Urinary tract catheter 14 (46.7) 106 (33.3) 120 (34.5)
Hemodialysis catheter 6 (20.0) 17 (5.3) 23 (6.6)
Nasogastric tube 0 (0.0) 2 (0.6) 2 (0.5)
Underlying disease conditions Stroke 7 (23.3) 66 (20.6) 73 (20.9)
UGIB 2 (6.7) 24 (7.5) 26 (7.4)
CCF + DCM 2 (6.7) 20 (6.3) 22 (6.3)
ESRD 0 (0.0) 22 (6.9) 22 (6.3)
Gastritis 1 (3.3) 17 (5.3) 18 (5.1)
CCF 1 (3.3) 16 (5.0) 17 (4.9)
HTN emergency 2 (6.7) 14 (4.4) 16 (4.6)
Anaemia 2 (6.7) 13 (4.1) 15 (4.3)
VOC + SCD 1 (3.3) 13 (4.1) 14 (4.0)
DKA + T2DM 1 (3.3) 9 (2.8) 10 (2.9)
Others** 11 (36.7) 106 (33.1) 117 (33.3)
Median [IQR] days of hospital stay 13.5 [12–15] 4 [3–5] 4 [3–6]
Hospital discharge status Died 2 (6.7) 41 (12.8) 43 (12.3)
Alive 28 (93.3) 279 (87.2) 307 (87.7)

KEY: CCF = congestive cardiac failure; GBW = generalized body weakness; DCM = dilated cardiomyopathy; DIB = difficulty in breathing; DKA = diabetic ketoacidosis; ESRD = end-stage renal disease; HTN = hypertension; NGT = nasogastric tube; UGIB = upper gastrointestinal bleeding; RRH = regional referral hospital; SCD = sickle cell disease; T2DM = type 2 diabetes mellitus; RTI = respiratory tract infection; VOC = vaso-occlusive crisis

Others*: ascites, blurry vision + headache, convulsion, dizziness, hematochezia, hemoptysis, melena, lower limb edema, paroxysmal nocturnal dyspnea, oliguria, and polyuria

Others**: rheumatic heart disease, asthma, cancer associated conditions, arrhythmia, colitis, epilepsy, cardiogenic shock, hepatitis B infection + liver cirrhosis, intestinal mass, migraine, cardiomyopathy, thyrotoxicosis, uremia, and unstable angina